Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1251, 2000-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefits of better β-cell function with anakinra in type 2 diabetes?
Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. :
Access to resources
Recommend
Inhaled insulin beneficial in type 2 diabetes?
Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. :
ACE inhibitors: a `prudent' approach in type 2 diabetes?
Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. :
Counting costs of diabetes? Better start early . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. :
Inhaled insulin a viable alternative in type 1 diabetes?
Inpharma, Vol. 1, Iss. 1274, 2001-01 ,pp. :